Clinical & translational oncology

• 

  Año 2022, Vol. 24, Número 11 (November)

  • Review Article

    • The role of liver kinase B1 in tumor progression through regulation of lipid metabolism

      Jialu Geng, Yanghe Zhang, Qingfei Meng, Hang Yan, Yishu Wang

      • Resumen

      págs. 2045-2054

      

    • MiRNAs in renal cell carcinoma

      Jesús Miranda, Lucía Trilla Fuertes, Elena López Camacho, Andrea Zapater Moros, Rocío López Vacas, María Isabel Lumbreras Herrera, Ana Pertejo Fernández, Juan Ángel Fresno Vara, E. Espinosa Arranz, Angelo Gámez Pozo, Alvaro Pinto Marín

      • Resumen

      págs. 2055-2063

      

    • AMPK’s double-faced role in advanced stages of prostate cancer

      Faeze Gharibpoor, Sara Kamali Zonouzi, Sepideh Razi, Nima Rezaei

      • Resumen

      págs. 2064-2073

      

    • Colorectal cancer-derived exosomes and modulation KRAS signaling

      Yan Hua Wan, Qi Sheng Liu, Sha Sha Wan, Ri Wei Wang

      • Resumen

      págs. 2074-2080

      

    • Long non-coding RNA signatures and related signaling pathway in T-cell acute lymphoblastic leukemia

      Homayon Yousefi, Daryush Purrahman, Mohammad Jamshidi, Elena Lak, Bijan Keikhaei, Mohammad-Reza Mahmoudian-Sani

      • Resumen

      págs. 2081-2089

      

  • Special Article

    • Bone loss induced by cancer treatments in breast and prostate cancer patients

      Santos Castañeda Sanz, A. M. Casas Fernández de Tejerina, Aránzazu González del Alba, Guillermo Martínez Díaz Guerra, Xavier Nogués Solán, Cristina Ojeda Thies, Oscar Torregrosa Suau, Álvaro Rodríguez Lescure

      • Resumen

      págs. 2090-2106

      

    • Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer

      Ruth Vera García, Carolina Ibarrola Andrés, Jorge Adeva, Judith Pérez Rojas, Pilar García Alfonso, Yolanda Rodriguez Gil, Teresa Macarulla Mercadé, Teresa Serrano Piñol, Rebeca Mondéjar Solís, Beatriz Madrigal Rubiales

      • Resumen

      págs. 2107-2119

      

  • Research Article

    • CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer

      Chih-Yi Lin, Chung-Jen Yu, Chun-Yu Liu, Ta-Chung Chao, Chi-Cheng Huang, Ling-Ming Tseng, Jiun-I. Lai

      • Resumen

      págs. 2120-2135

      

    • Effect of cell density on the malignant biological behavior of breast cancer by altering the subcellular localization of ANXA2 and its clinical implications

      Jingtai Chen, Xiaohan Su, Qiao Tan, Hongyu Pu, Linxing Zhang, Yuqing Kang, Yunhui Tang, Xiaobo Zhao, Wei Hou, Shuangqiang Qian, Shishan Deng, Lingmi Hou, Yanchun Gao

      • Resumen

      págs. 2136-2145

      

    • Timing of radiotherapy in glioblastoma based on IMRT and STUPP chemo-radiation: may be no need to rush

      Shan Li, Feibao Guo, Xuezhen Wang, Jiang Zeng, Jinsheng Hong

      • Resumen

      págs. 2146-2154

      

    • Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)

      Jorge Aparicio Urtasun, Anna C. Virgili Manrique, Jaume Capdevila Castillon, Félix Muñoz Boza, Patricia Galván, Paula Richart Aznar, Helena Oliveres, David Páez López-Bravo, Jorge Hernando Cubero, Sara Serrano Solares, Ruth Vera García, X. Hernández Yagüe, Rafael Alvarez Gallego, María Carmen Riesco Martínez, Xabier Adrián García de Albéniz Martínez, Joan Maurel Santasusana

      • Resumen

      págs. 2155-2165

      

    • BMI1 promotes the proliferation and inhibits autophagy of breast cancer cells by activating COPZ1

      Shuming Chen, He Li, Siyu Chen, Bing Wang, Kaixiang Zhang

      • Resumen

      págs. 2166-2174

      

    • Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy

      Mercedes Camacho, Xavier León Vintró, Albert Pujol Olmo, Laura Montezuma, Miquel Quer, Jacinto García Lorenzo

      • Resumen

      págs. 2175-2180

      

    • Characteristics of gut microbiota in patients with gastric cancer by surgery, chemotherapy and lymph node metastasis

      Changchang Chen, Jian Shen, Yaoqiang Du, Xinwei Shi, Yaofang Niu, Gulei Jin, Yanxin Liu, Yongkang Shi, Jianxin Lyu, Lijun Lin

      • Resumen

      págs. 2181-2190

      

    • Expression pattern and clinical significance of beta 2-adrenergic receptor in oral squamous cell carcinoma: an emerging prognostic indicator and future therapeutic target

      Akhilesh Krishna, Vineeta Singh, Nishtha Singh, Shraddha Singh, Sujit Kumar Mohanty, Rajender Singh, Vijay Kumar, Uma S. Singh, Rakesh Kumar Singh

      • Resumen

      págs. 2191-2199

      

    • The application value of CDFI and SMI combined with serological markers in distinguishing benign and malignant thyroid nodules

      Fang Li, Wei Sun, Lihua Liu, Zhen Meng, Jianli Su

      • Resumen

      págs. 2200-2209

      

    • Resveratrol inhibits TGF-β1-induced EMT in gastric cancer cells through Hippo-YAP signaling pathway

      Lei Deng, Jun Zou, Yongfeng Su, Meijian Wang, Lianwu Zhao

      • Resumen

      págs. 2210-2221

      

    • IL-6 secretion of CD4+ T cells stimulated by LC3-positive extracellular vesicles in human epithelial ovarian cancer

      Xiu-Lin Zhu, Hao-Jue Wang, Xu-Ru Wang, Di Wu, Xuan Ji, Li Xu, Qi Yang, Jie-Ying Guo, Yan Rong, Ning Pan, Yun-lang Cai

      • Resumen

      págs. 2222-2230

      

    • Establishment of an acquired lorlatinib-resistant cell line of non-small cell lung cancer and its mediated resistance mechanism

      Bo Xie, Ying Qiu, Juan Zhou, Dou Du, Haochuan Ma, Jiapeng Ji, Liquan Zhu, Weimin Zhang

      • Resumen

      págs. 2231-2240

      

    • Excess weight and anti-PD-1 immune checkpoint inhibitor’s outcomes in non-small cell lung cancer

      Jacobo Rogado Revuelta, Fernando Pozo, Kevin Troulé Lozano, José Miguel Sánchez Torres, Nuria Romero Laorden, Rebeca Mondéjar Solís, Olga Donnay Candil, Ana Isabel Ballesteros García, Vilma Emilia Pacheco Barcia, Javier Aspa Marco, Fátima Al-Shahrour, Arántzazu Alfranca González, Ramón Colomer Bosch

      • Resumen

      págs. 2241-2249

      

  • Correction

    • Correction to. Bone loss induced by cancer treatments in breast and prostate cancer patients

      Santos Castañeda Sanz, A. M. Casas Fernández de Tejerina, Aránzazu González del Alba, Guillermo Martínez Díaz Guerra, Xavier Nogués Solán, Cristina Ojeda Thies, Oscar Torregrosa Suau, Álvaro Rodríguez Lescure

      págs. 2250-2250

      

    • Correction to. CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer

      Chih-Yi Lin, Chung-Jen Yu, Chun-Yu Liu, Ta-Chung Chao, Chi-Cheng Huang, Ling-Ming Tseng, Jiun-I. Lai

      págs. 2251-2253